 acyclovir therapi neonat studi object pharmacokinet paramet acyclovir disposit neonat renal dysfunct design prospect sequenti open enrol neonat presum herp group viru infect set neonat intens care unit paul metropolitan area patient sixteen neonat gestat age week median week acyclovir day life presum herp viru infect infant ill multisystem diseas infant hepat failur underw blood exchang transfus infant renal failur mean rang serum acyclovir concentr patient radioimmunoassay pharmacokinet paramet acyclovir concentr sampl patient measur main result pharmacokinet disposit acyclovir two-compart model rang acyclovir clearanc termin elimin beta wide signific relationship clearanc beta versu serum creatinin concentr averag beta infant serum creatinin level mg/dl mumol/l hour hour serum creatinin level mg/dl conclus neonat hepat renal dysfunct young prematur infant acyclovir adjust organ dysfunct measur serum creatinin creatinin clearanc use dose acyclovir neonat